ADVERSE OUTCOMES IN SUBSEQUENT PREGNANCIES IN THE IMPAACT 2010 TRIAL
Few studies have prospectively captured pregnancy outcomes among women living with HIV (WLHIV) who conceive on antiretroviral treatment (ART). IMPAACT 2010 (VESTED) enrolled 643 WLHIV at 14-28 weeks gestational age in 9 countries. Women were randomized to start ART with dolutegravir (DTG) plus emtricitabine (FTC)/tenofovir alafenamide (TAF); DTG+FTC/tenofovir disoproxil fumarate (TDF); or efavirenz (EFV)/FTC/TDF. Due…